
Measuring Tremor Between Visits: What Sine Health's Smartphone Clearance Does and Does Not Prove for Essential Tremor Care
Dr. Dereck Mush, MD, MBAMedical device company making the ExAblate Neuro MR-guided focused ultrasound system.
Insightec is a medical device company that makes the ExAblate Neuro MR-guided focused ultrasound system. FDA records list its address in Tirat Carmel, Israel. On July 11, 2016, the FDA approved PMA P150038 for ExAblate Model 4000 Type 1.0 (ExAblate Neuro) for unilateral thalamotomy in patients aged 22 or older with idiopathic essential tremor and medication-refractory tremor. On December 8, 2022, the FDA approved PMA supplement P150038/S022, a labeling change to the indications for use in idiopathic essential tremor patients with medication-refractory tremor.
How Insightec got here, step by step.
11 July 2016
The FDA approved ExAblate Model 4000 Type 1.0 (ExAblate Neuro) for unilateral thalamotomy in patients aged 22 or older with idiopathic essential tremor and medication-refractory tremor.
8 December 2022
The FDA approved a labeling change to the indications for use in idiopathic essential tremor patients with medication-refractory tremor.
8 December 2022
FDA labeling supplement: P150038/S02211 July 2016
FDA approval record: ExAblate Neuro, P150038
Dr. Dereck Mush, MD, MBAMentions Insightec

Dr. Dereck Mush, MD, MBAMentions Insightec
Related companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: